Article
Genetics of myeloproliferative neoplasms.
Cancer journal (Sudbury, Mass.) - 1 Jan 2000
Viny Aaron D, Levine Ross L
Abstract excerpt
In the last decade, genomic studies have identified multiple recurrent somatic mutations in myeloproliferative neoplasms (MPNs). Beginning with the discovery of the JAK2 V617F mutation, multiple additional mutations have been found that constitutively activate cell-signaling pathways, including MPL, CBL, and LNK. Furthermore, several classes of epigenetic modifiers have also been identified, in patients with MPN,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
